C. Leyrat

First name
C.
Last name
Leyrat
Baptiste, P. J., Wong, A. Y. S., Schultze, A., Clase, C. M., Leyrat, C., Williamson, E., et al. (2024). Cardiorenal effects of Angiotensin-converting enzyme inhibitors and Angiotensin receptor blockers in people underrepresented in trials: analysis of routinely collected data with emulation of a reference trial (ONTARGET). Am J Epidemiol. http://doi.org/10.1093/aje/kwae137
View
. Y. Wong, A., Warren-Gash, C., Bhaskaran, K., Leyrat, C., Banerjee, A., Smeeth, L., & Douglas, I. J. (2024). Potential interactions between medications for rate control and direct oral anticoagulants: population-based cohort and case-crossover study. Heart Rhythm. http://doi.org/10.1016/j.hrthm.2024.06.033
View
Brown, J. P., Wing, K., Evans, S. J., Leyrat, C., Mansfield, K. E., Smeeth, L., et al. (2024). Systemic Fluoroquinolone Use and Risk of Uveitis or Retinal Detachment. Jama Ophthalmol. http://doi.org/10.1001/jamaophthalmol.2024.1712
View
Brown, J. P., Wing, K., Leyrat, C., Evans, S. J., Mansfield, K. E., Wong, A. Y. S., et al. (2023). Association Between Fluoroquinolone Use and Hospitalization With Aortic Aneurysm or Aortic Dissection. Jama Cardiol. http://doi.org/10.1001/jamacardio.2023.2418
View
Bhate, K., Mansfield, K. E., Sinnott, S. J., Margolis, D. J., Adesanya, E., Francis, N., et al. (2022). Long-term oral antibiotic use in people with acne vulgaris in UK primary care: a drug utilization study. Br J Dermatol. http://doi.org/10.1093/bjd/ljac084
View
Davidson, J. A., Banerjee, A., Douglas, I., Leyrat, C., Pebody, R., McDonald, H. I., et al. (2022). Primary prevention of acute cardiovascular events by influenza vaccination: an observational study. Eur Heart J. http://doi.org/10.1093/eurheartj/ehac737
View
Baptiste, P. J., Wong, A. Y. S., Schultze, A., Cunnington, M., Mann, J. F. E., Clase, C., et al. (2022). Effects of ACE inhibitors and angiotensin receptor blockers: protocol for a UK cohort study using routinely collected electronic health records with validation against the ONTARGET trial. Bmj Open, 12, e051907. http://doi.org/10.1136/bmjopen-2021-051907
View
Crellin, E., Mansfield, K. E., Leyrat, C., Nitsch, D., Douglas, I. J., Root, A., et al. (2018). Trimethoprim use for urinary tract infection and risk of adverse outcomes in older patients: cohort study. Bmj. http://doi.org/10.1136/bmj.k341
View
Bidulka, P., Fu, E. L., Leyrat, C., Kalogirou, F., McAllister, K. S. L., Kingdon, E. J., et al. (2020). Stopping renin-angiotensin system blockers after acute kidney injury and risk of adverse outcomes: parallel population-based cohort studies in English and Swedish routine care. BMC Med. http://doi.org/10.1186/s12916-020-01659-x
View
Greenhall, G. H. B., Mansfield, K. E., Nitsch, D., Iwagami, M., Leyrat, C., Johnston, R., et al. (2020). The effect of initiation of renin-angiotensin system inhibitors on haemoglobin: A national cohort study. Br J Clin Pharmacol. http://doi.org/10.1111/bcp.14429
View